EUVIMEDEUVIMED entdecken
Crossref

Risk Genes and Anti‐C1q Autoantibodies in Upper Egyptian Patients With Systemic Lupus Erythromatosis—High Frequency of HLA‐DRB1*04:05–DQA1*03–DQB1*02 Risk Haplotype in Lupus Nephritis Patients

Mostafa I El-Amir iD, Mohamed Ali El-Feky, Abdelkader Ahmed Hashim, Mohammed H Hassan iD, Marwa Abdelhady, Wael Abd El Mohsen Abady, Amr Mohamed ElKaber, Jorma Ilonen

International Journal of Immunogenetics · 2025

DOI: 10.1111/iji.70009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Immunogenetics, 2025. Verfasst von Mostafa I El-Amir und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Microbiology and Immunology, Faculty of Medicine, South Valley University, Qena, Egypt. Hauptthemen laut MEDLINE: HLA-DRB1 Chains, Lupus Nephritis, HLA-DQ beta-Chains, HLA-DQ alpha-Chains. Die Arbeit nennt 35 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study was performed to determine anti‐C1q serum level, genetic polymorphism in cytotoxic T lymphocyte–associated antigen 4 gene (CTLA‐4 gene) (rs 231775), and HLA class II genes in susceptibility and early prediction of systemic lupus erythematosus (SLE) and lupus nephritis (LN) in Upper Egyptian patients. A total of 60 unrelated cases of SLE (30 cases with LN) and 60 healthy controls were studied for HLA‐DQB1, HLA‐DQA1, and HLA‐DRB1 (DR4 subtypes) alleles. Anti‐C1q level was estimated by ELISA. CTLA‐4 gene genotypes were detected by PCR‐RFLP. The means of age of SLE patients without nephritis and LN patients were 24 ± 5.09 and 32 ± 7.26, respectively. Most of the patients were females (93.3%). Anti‐C1q serum level was significantly higher in LN patients (24.11 ± 4.26) versus SLE patients without nephritis (18.17 ± 1.35) ( p value < 0.001). The AA genotype of the CTLA‐4 gene was significantly higher in patients with LN versus SLE patients without nephritis (53.5% vs. 26.5%; p value = 0.035). (DR7)—DQA1*02‐DQB1*0303 haplotype was higher in SLE patients versus the control group and showed the highest odds ratio (7.37) with a significant p value (0.031). Odds ratios of DRB1*0405–DQA1*03–DQB1*0302 and DRB1*0405–DQA1*03–DQB1*02 were 6.263 and 4.214, respectively. DRB1*0405–DQA1*03–DQB1*02 haplotype was detected in 11.7% of LN patients versus 1.7% of SLE patients without nephritis (OR = 8.82, p value = 0.02). DRB1*0405–DQA1*03–DQB1*02 haplotype, in addition to CTLA‐4 gene (AA genotype), and high anti‐C1q serum level can predict the progression of SLE Upper Egyptian patients to LN.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HLA-DRB1 ChainsLupus NephritisHLA-DQ beta-ChainsHLA-DQ alpha-ChainsAutoantibodiesComplement C1qLupus Erythematosus, SystemicHumansFemaleMaleAdultGenetic Predisposition to DiseaseEgyptHaplotypesCTLA-4 AntigenGene FrequencyGenotypeYoung AdultAllelesAdolescentCase-Control Studies

Stichwörter der Autor:innen

CTLA‐4 gene (rs 231775)HLASLEanti‐C1q

Substanzen

HLA-DRB1 ChainsHLA-DQ beta-ChainsHLA-DQ alpha-ChainsAutoantibodiesHLA-DQB1 antigenHLA-DQA1 antigenCTLA-4 AntigenComplement C1qCTLA4 protein, human

Autor:innen und Institutionen

  • Department of Medical Microbiology and Immunology, Faculty of Medicine, South Valley University, Qena, Egypt.
  • Department of Medical Microbiology and Immunology, Faculty of Medicine, Assiut University, Assiut, Egypt.
  • Department of Internal Medicine, Faculty of Medicine, South Valley University, Qena, Egypt.
  • Department of Biochemistry, Faculty of Medicine, South Valley University, Qena, Egypt.
  • Department of Internal Medicine, Faculty of Medicine, Luxor University, Luxor, Egypt.
  • Department of Physical Medicine, Rheumatology, and Rehabilitation, Faculty of Medicine, South Valley University, Qena, Egypt.

ORCID-Profile: Mostafa I El-Amir, Mohammed H Hassan

Zitieren

APA

El-Amir, M. I., El-Feky, M. A., Hashim, A. A., Hassan, M. H., Abdelhady, M., Abady, W. A. E. M., ElKaber, A. M., & Ilonen, J. (2025). Risk Genes and Anti‐C1q Autoantibodies in Upper Egyptian Patients With Systemic Lupus Erythromatosis—High Frequency of HLA‐DRB1*04:05–DQA1*03–DQB1*02 Risk Haplotype in Lupus Nephritis Patients. International Journal of Immunogenetics. https://doi.org/10.1111/iji.70009

Vancouver

El-Amir MI, El-Feky MA, Hashim AA, Hassan MH, Abdelhady M, Abady WAEM, et al. Risk Genes and Anti‐C1q Autoantibodies in Upper Egyptian Patients With Systemic Lupus Erythromatosis—High Frequency of HLA‐DRB1*04:05–DQA1*03–DQB1*02 Risk Haplotype in Lupus Nephritis Patients. International Journal of Immunogenetics. 2025. doi:10.1111/iji.70009

BibTeX
@article{ElAmir2025,
  author = {El-Amir, Mostafa I and El-Feky, Mohamed Ali and Hashim, Abdelkader Ahmed and Hassan, Mohammed H and Abdelhady, Marwa and Abady, Wael Abd El Mohsen and ElKaber, Amr Mohamed and Ilonen, Jorma},
  title = {Risk Genes and Anti‐C1q Autoantibodies in Upper Egyptian Patients With Systemic Lupus Erythromatosis—High Frequency of HLA‐DRB1*04:05–DQA1*03–DQB1*02 Risk Haplotype in Lupus Nephritis Patients},
  journal = {International Journal of Immunogenetics},
  year = {2025},
  doi = {10.1111/iji.70009}
}
Kostenlos starten →